Daily News Podcast

FDA approves Zephyr valves for emphysema


 

The Food and Drug Administration has approved the Zypher endobronchial valve system for patients with severs emphysema who are experiencing difficulty breathing. Also today, meth use is climbing alongside the opioid epidemic, pain remains after rheumatoid arthritis diagnosis, and higher RA biologic drug levels linked with more infections. Subscribe to the MDedge Daily News for today’s top news.

Recommended Reading

Impact of varicella vaccination on herpes zoster is not what was expected
MDedge Hematology and Oncology
Galectin-3: A post-MI prognostic biomarker for our times
MDedge Hematology and Oncology
Herpesvirus infections may have a pathogenic link to Alzheimer’s disease
MDedge Hematology and Oncology
Patients going without as insulin prices skyrocket
MDedge Hematology and Oncology
FDA approves Epidiolex for both Lennox-Gastaut syndrome and Dravet syndrome
MDedge Hematology and Oncology
Opioids do more harm than good for musculoskeletal pain
MDedge Hematology and Oncology
Addiction: Veterans with pain, opioid use disorder
MDedge Hematology and Oncology
Medicare beneficiaries are dying differently
MDedge Hematology and Oncology
European Medicines Agency recommends CAR T-cell approvals
MDedge Hematology and Oncology
Updated anthrax vaccine recommendations
MDedge Hematology and Oncology